Addiction Treatment: Non 12 Step, Non AA, Medical Model. Presented by the American Health Journal.

Addiction Treatment: Non 12 Step, Non AA, Medical Model. Presented by The American Health Journal. – **THIS TREATMENT AVAILABLE AT THE BRAIN TREATMENT CENTER** www.braintreatmentcenter.com http www.Non12.com http Brookside Institute offers treatment protocol that combines the latest in neuroscience (TMS Neurofeedback), cognitive behavioral therapy (CBT) and medicine to treat addiction and co-occurring disorders (dual diagnosis). Unlike other treatment centers that may offer “non 12 step programs” the Brookside Recovery Protocol ™ is a science-based, medical model that applies over twenty years of scientific research to provide a comprehensive treatment for addiction. Although other treatment programs may claim to be non 12 step, none provide the same level of care and innovative approach to addiction as Brooksides individualized, all-inclusive treatment protocol. Many programs have recently jumped on the non 12 step trend; however, Brookside Institute is the pioneer in science-based, medical model treatment for addiction and has always used this model to treat addiction. At the Neuroscience Center we use TMS and Neurofeedback as treatment. Magno-EEG Resonant Therapy (MERT) is an innovative treatment procedure using a noninvasive electromagnetic resonant process to tune up or down specific brainwaves. This is a refined process of the traditional Transcranial Magnetic Stimulation (TMS) that is unique to Brookside Institute NeuroScience Center. Unlike TMS, MERT is precisely calculated based on the individuals electroencephalography (EEG) to deliver the perfect combination …

Use of Xarelto Expanded to Treat Blood Clots

Filed under: drug treatment programs in dc

Washington, D.C. – infoZine – The U.S. Food and Drug Administration expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following …
Read more on Kansas City infoZine

Boehringer Ingelheim to Pay Million to Resolve False Claims Act Allegations

Filed under: drug treatment programs in dc

Washington, DC – Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $ 95 million to resolve allegations relating to the improper promotion of the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease (COPD …
Read more on Yumanewsnow